Login / Signup

Is mass screening for coeliac disease a wise use of resources? A health economic evaluation.

Fredrik NorströmAnna MyléusKatrina NordykeAnnelie CarlssonLotta HögbergOlof SandströmLars StenhammarAnneli IvarssonLars Lindholm
Published in: BMC gastroenterology (2021)
A coeliac disease mass screening is cost-effective based on the commonly used threshold of 50,000 Euro per gained QALY. However, this is based on many assumptions, especially regarding the natural history of coeliac disease and the effects on long-term health for individuals with coeliac disease still eating gluten.
Keyphrases
  • mental health
  • health information
  • human health